559 results on '"Bach, Richard G."'
Search Results
2. Association Between age or Duration of Diagnosis in Obstructive Hypertrophic Cardiomyopathy and Response to Mavacamten Treatment: Exploratory Analysis of the EXPLORER-HCM Trial
3. Effect of Mavacamten in Women Compared With Men With Obstructive Hypertrophic Cardiomyopathy: Insights From EXPLORER-HCM
4. Abstract 15696: Simultaneous Presentation of ST-Elevation Myocardial Infarction, Ischemic Stroke, and Pulmonary Embolism in a Patient With Thrombus-in-Transit Across a Patent Foramen Ovale
5. Abstract 12135: Quality of Life in Early-Stage Hypertrophic Cardiomyopathy: A Secondary Analysis of the VANISH Trial
6. Abstract 12690: Mavacamten Treatment in Patients With Obstructive and Nonobstructive Hypertrophic Cardiomyopathy: A Pooled Safety Analysis of 5 Clinical Trials
7. Improving Care Pathways for Acute Coronary Syndrome: Patients Undergoing Percutaneous Coronary Intervention
8. Incremental Cost of Acute Kidney Injury after Percutaneous Coronary Intervention in the United States
9. Exercise Testing to Unmask Latent LVOT Obstruction in a Highly Symptomatic Patient With Hypertrophic Cardiomyopathy.
10. Quality of Life and Exercise Capacity in Early Stage and Subclinical Hypertrophic Cardiomyopathy: A Secondary Analysis of the VANISH Trial.
11. Effect of Mavacamten in Women Compared With Men With Obstructive Hypertrophic Cardiomyopathy: Insights From EXPLORER-HCM
12. In ischemic LV dysfunction, adding PCI to medical therapy did not reduce a composite of death or aborted sudden death
13. Traditional Chinese Medicine Meets Evidence-Based Medicine in the Acutely Infarcted Heart
14. Left Ventricular Unloading by Impella Device Versus Surgical Vent During Extracorporeal Life Support
15. D-25 | Cangrelor Use in Cardiogenic Shock - Findings from the CAMEO Registry
16. Response by Amin et al to Letters Regarding Article, “The Evolving Landscape of Impella Use in the United States Among Patients Undergoing Percutaneous Coronary Intervention With Mechanical Circulatory Support”
17. In severe tricuspid regurgitation, tricuspid TEER improved QoL more than medical therapy at 1 y
18. The Evolving Landscape of Impella Use in the United States Among Patients Undergoing Percutaneous Coronary Intervention With Mechanical Circulatory Support
19. Contributors
20. Adjunctive Pharmacologic Therapies in Acute Myocardial Infarction
21. Reducing Acute Kidney Injury and Costs of Percutaneous Coronary Intervention by Patient-Centered, Evidence-Based Contrast Use: The Barnes-Jewish Hospital Experience
22. Hemodynamics during Arrhythmias
23. Transforming Growth Factor-β Analysis of the VANISH Trial Cohort
24. WOMEN IN EXPLORER-HCM HAD MORE SEVERE HEART FAILURE AT BASELINE BUT SIMILAR, OR GREATER, RESPONSE TO MAVACAMTEN
25. THE EFFECT OF MAVACAMTEN TREATMENT FOR SYMPTOMATIC, OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY IN PATIENTS OF OLDER AGE AND LONGER DURATION OF DIAGNOSIS: ANALYSIS OF THE EXPLORER-HCM TRIAL
26. OBSTRUCTIVE HCM PATIENTS IN EXPLORER-HCM WITH HIGH LEFT VENTRICULAR FILLING PRESSURES HAD MORE SEVERE HEART FAILURE BUT SIMILAR OR GREATER RESPONSE TO MAVACAMTEN
27. Intra-Aortic Balloon Counterpulsation in Patients With Chronic Heart Failure and Cardiogenic Shock: Clinical Response and Predictors of Stabilization
28. Outcomes of Coronary Stenoses Deferred Revascularization for Borderline Versus Nonborderline Fractional Flow Reserve Values
29. CHRNA5 Variant Predicts Smoking Cessation in Patients With Acute Myocardial Infarction
30. Cardiac Remodeling in Subclinical Hypertrophic Cardiomyopathy: The VANISH Randomized Clinical Trial.
31. A novel genetic marker of decreased inflammation and improved survival after acute myocardial infarction
32. Impact of Drug Eluting Stent Length on Outcomes of Percutaneous Coronary Intervention (from the EVENT Registry)
33. Long-Term Outcomes With Use of Intravascular Ultrasound for the Treatment of Coronary Bifurcation Lesions
34. Coronary Stenosis Morphology: Importance of Lesion Length, Stenosis Eccentricity, Severity and Coronary Blood Flow in Clinical Decision Making
35. Current status and future expectations of the flow velocity guidewire
36. Hospital-acquired anemia and in-hospital mortality in patients with acute myocardial infarction
37. DAPT de-escalation from ticagrelor to clopidogrel 1 mo after PCI for acute MI reduced net clinical events at 1 y
38. Predicting long‐term bleeding after percutaneous coronary intervention
39. Repeat revascularisation outcomes after percutaneous coronary intervention in patients with rheumatoid arthritis
40. Echocardiographic Tissue Characterization Demonstrates Differences in the Left and Right Sides of the Ventricular Septum
41. Impact of Intravascular Ultrasound on the Long-Term Clinical Outcomes in the Treatment of Coronary Ostial Lesions
42. Baseline Coronary Angiographic Findings in the Bypass Angioplasty Revascularization Investigation 2 Diabetes Trial (BARI 2D)
43. Abstract 9685: Long-Term Efficacy and Safety of Mavacamten in Patients with Non-Obstructive Hypertrophic Cardiomyopathy: Interim Results from the MAVERICK-LTE Cohort of the MAVA-LTE Study
44. Syndrome of Reversible Cardiogenic Shock and Left Ventricular Ballooning in Obstructive Hypertrophic Cardiomyopathy
45. Risk model for estimating the 1-year risk of deferred lesion intervention following deferred revascularization after fractional flow reserve assessment
46. The efficacy of ticagrelor is maintained in women with acute coronary syndromes participating in the prospective, randomized, PLATelet inhibition and patient Outcomes (PLATO) trial
47. Conversations in Cardiology: Bridging antiplatelet therapy before surgery
48. In vivo IVUS-based 3-D fluid--structure interaction models with cyclic bending and anisotropic vessel properties for human atherosclerotic coronary plaque mechanical analysis
49. Valsartan in early-stage hypertrophic cardiomyopathy:a randomized phase 2 trial
50. Transradial Access for High-Risk Percutaneous Coronary Intervention: Implications of the Risk-Treatment Paradox
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.